Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments

Patient Preference and Adherence

Volumn 9, Issue , 2015, Pages 569-578

  Pérez Escamilla, Beatriz ^a   Franco Trigo, Lucía ^a   Moullin, Joanna C ^b   Martínez Martínez, Fernando ^a   García Corpas, José P ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Compliance; Hypertension; Medication; Reliability; Scale; Validation; Validity

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BRIEF MEDICATION QUESTIONNAIRE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CRITERION RELATED VALIDITY; DATA ANALYSIS; DRUG DATABASE; HILL BONE COMPLIANCE TO HIGH BLOOD PRESSURE THERAPY SCALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; MARTIN BAYARRE GRAU QUESTIONNAIRE; MORISKY GREEN LEVINE QUESTIONNAIRE; MORISKY MEDICATION ADHERENCE SCALE; PATIENT COMPLIANCE; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT ADHERENCE QUESTIONNAIRE FOR PATIENTS WITH HYPERTENSION; VALIDATION STUDY;

EID: 84934762538     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S76139     Document Type: Review

References (48)

1. Côté I, Moisan J, Chabot I, Grégoire JP. Health-related quality of life in hypertension: impact of a pharmacy intervention programme. J Clin Pharm Ther. 2005;30(4):355–362.
2. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25(3):512–516.
3. Gascón Cánovas JJ, Saturno Hernández PJ, Llor Esteban B; Grupo de Investigación del Proyecto EMCA sobre Evaluación y Mejora de la Adhesión Terapéutica en la Hipertensión. [Evaluation and improvement of therapy adherence of hypertensive patients]. Aten Primaria. 2001;28(9):615–619. Spanish.
4. Berry SD, Quach L, Procter-Gray E, et al. Poor adherence to medications may be associated with falls. J Gerontol A Biol Sci Med Sci. 2010;65(5):553–558.
5. Espinosa Garcia J, Martell Claros N, Llerena Ruiz A, Fernández Bergés Gurrea D. [Pharmacological compliance in the treatment of arterial hypertension. A review of studies published between 1975 and 2011]. Semergen. 2012;38(5):292–300.
6. Nunnally JC, Bernstein IH. Teoría Psicométrica. [Psychometric theory]. 3rd ed. Mexico DF: McGraw-Hill Inc; 1995. Spanish.
7. Ben AJ, Neumann CR, Mengue SS. The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence. Rev Saude Publica. 2012;46(2):279–289.
8. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15(3):90–96.
9. Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16(1):286–291.
10. Song Y, Han HR, Song HJ, Nam S, Nguyen T, Kim MT. Psychometric evaluation of hill-bone medication adherence subscale. Asian Nurs Res (Korean Soc Nurs Sci). 2011;5(3):183–188.
11. Korb-Savoldelli V, Gillaizeau F, Pouchot J, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich). 2012;14(7):429–434.
12. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354.
13. Saleem F, Hassali MA, Shafie AA, et al. Translation and validation study of Morisky Medication Adherence Scale (MMAS): the Urdu version for facilitating person-centered healthcare in Pakistan. Int J Pers Cent Med. 2012;2(3):384–390.
14. Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension. J Adv Nurs. 2012;68(6):1402–1413.
15. Martin Alfonso L, Bayarre Vea HD, Grau Ábalo JA. Validation of MBG Questionnaire (Martin-Bayarre-Grau) for the evaluation of therapy adherence in blood hypertension patients. Rev Cuba Salud Publica. 2008:34(1). Spanish.
16. Martínez JW, Villa Perea JA, Jaramillo J, Quintero Betancur AM, Calderón V. Validación del cuestionario de adherencia al tratamiento anti hipertensivo Martín Bayarré Grau. [Validation of a scale of adherence treatment antihypertensive: Martin Bayarre Grau Test]. Rev Med Risaralda. 2011;17(2):101–105. Spanish.
17. Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D. Impact of a community pharmacists’ hypertension-care service on medication adherence. The AFenPA study. Res Social Adm Pharm. 2013;9(6):797–805.
18. Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330(3):128–133.
19. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804.
20. Jing S, Naliboff A, Kaufman MB, Choy M. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members. J Manag Care Pharm. 2011;17(5):355–366.
21. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1):76–87.
22. Haynes RB, Taylor DL, Sackett D. Compliance in Health Care. Baltimore, MD: John Hopkins University Press; 1979.
23. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993;72(10):68D–74D.
24. World Health Organization. Adherencia a los Tratamientos a Largo Plazo. [Adherence to long-term therapies]. Geneva: World Health Organization; 2004. Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=18722&Itemid=>. Accessed, July 2, 2013. Spanish.
25. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
26. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–342.
27. Gozum S, Hacihasanoglu R. Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. Eur J Cardiovasc Nurs. 2009;8(2):129–136.
28. Gutiérrez-Angulo ML, Lopetegi-Uranga P, Sánchez-Martin I, Garaigordobil-Landazabal M. [Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus]. Rev Calid Asist. 2012;27(2):72–77. Spanish.
29. Amado Guirado E, Pujol Ribera E, Pacheco Huergo V, Borras JM; ADIEHTA Group. Knowledge and adherence to antihypertensive therapy in primary care: results of a randomized trial. Gac Sanit. 2011;25(1):62–67.
30. Gascón JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ; Treatment Compliance in Hypertension Study Group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004;21(2):125–130.
31. Morales Suárez-Varela MT; GEMECOR. [Study on the use of a smart pillbox to improve treatment compliance]. Aten Primaria. 2009;41(4):185–191. Spanish.
32. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
33. Lamprea JAM, Gómez Restrepo C. Validez en la evaluación de escalas [Validity in scale-testing]. Rev Colomb Psiquiat. 2007;36(2):340–348.
34. Sánchez Pedraza R, Gómez Restrepo CI. Conceptos básicos sobre validación de escalas. [Basic concepts on validation]. Rev Colomb Psiquiat. 1998;27(2):121–130. Spanish.
35. Polit DF, Beck CT. Assessing Data Quality. In: Nursing Research. Principles and Methods. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1995:413–448.
36. Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. 2007;10 Suppl 2:S94–S105.
37. Norman SA, Marconi KM, Schezel GW, Schechter CF, Stolley PD. Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med. 1985;1(3):10–17.
38. Stamler R, Stamler J, Civinelli J, et al. Adherence and blood-pressure response to hypertension treatment. Lancet. 1975;2(7947):1227–1130.
39. Schoenberg NE. The relationship between perceptions of social support and adherence to dietary recommendations among African-American elders with hypertension. Int J Aging Hum Dev. 1998;47(4):279–297.
40. Svensson S, Kjellgren KI. Adverse events and patients’ perceptions of antihypertensive drug effectiveness. J Hum Hypertens. 2003;17(10):671–675.
41. Bittar N. Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol. 1995;18(6 Suppl 3): 312–316.
42. Klein LE. Compliance and blood pressure control. Hypertension. 1988;11(3 Pt 2):261–264.
43. Scholz U, Gutiérrez Doña B, Sud S, Schwarzer R. Is general self-efficacy a universal construct? Psychometric findings from 25 countries. Eur J Psychol Assess. 2002;18(3):242–251.
44. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–124.
45. Batalla Martínez C, Blanquer Laguarta A, Ciurana Misol R, et al. Cumplimiento de la prescripción farmacológica en pacientes hipertensos. [Compliance with drug prescriptions in hypertensive patients]. Aten Primaria. 1984;1(2):185–191. Spanish.
46. Streiner D, Norman G. Health Measurement Scales. A Practical Guide to Their Development and Use: 2nd ed. New York, NY: Oxford University Press; 1991.
47. Quintana Setién C, Fernández-Britto Rodríguez JE. Adherencia terapéutica farmacológica antihipertensiva en adultos de atención primaria y factores relacionados con su incumplimiento. [Antihypertensive drug therapy compliance by adults in the primary health care and factors related to non-compliance]. Rev Cubana Invest Bioméd. 2009;28(2). Spanish.
48. Bland JM, Altman DG. Cronbach’s alpha. BMJ. 1997;314(7080):572.